Lymphatic distribution considerations for subunit vaccine design and development.

Autor: Hartmeier PR; Graduate School of Pharmaceutical Sciences, School of Pharmacy, Duquesne University, Pittsburgh, PA 15282, USA., Ostrowski SM; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, PA 15213, USA., Busch EE; Graduate School of Pharmaceutical Sciences, School of Pharmacy, Duquesne University, Pittsburgh, PA 15282, USA., Empey KM; Center for Clinical Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, USA; Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, PA 15213, USA; Department of Immunology, School of Medicine University of Pittsburgh, PA 15213, USA., Meng WS; Graduate School of Pharmaceutical Sciences, School of Pharmacy, Duquesne University, Pittsburgh, PA 15282, USA; McGowan Institute for Regenerative Medicine, University of Pittsburgh, PA 15219, USA. Electronic address: meng@duq.edu.

Publikováno v: Vaccine [Vaccine] 2024 Apr 11; Vol. 42 (10), pp. 2519-2529. Date of Electronic Publication: 2024 Mar 16.

Modeling the kinetics of lymph node retention and exposure of a cargo protein delivered by biotin-functionalized nanoparticles.

Autor: Hartmeier PR; Graduate School of Pharmaceutical Sciences, School of Pharmacy, Duquesne University, Pittsburgh, PA 15282, USA., Kosanovich JL; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, PA 15219, USA., Velankar KY; Graduate School of Pharmaceutical Sciences, School of Pharmacy, Duquesne University, Pittsburgh, PA 15282, USA., Ostrowski SM; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, PA 15219, USA., Busch EE; Graduate School of Pharmaceutical Sciences, School of Pharmacy, Duquesne University, Pittsburgh, PA 15282, USA., Lipp MA; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, PA 15219, USA., Empey KM; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, PA 15219, USA; Department of Immunology, School of Medicine, University of Pittsburgh, PA 15219, USA. Electronic address: kme33@pitt.edu., Meng WS; Graduate School of Pharmaceutical Sciences, School of Pharmacy, Duquesne University, Pittsburgh, PA 15282, USA; McGowan Institute for Regenerative Medicine, University of Pittsburgh, PA 15219, USA. Electronic address: meng@duq.edu.

Publikováno v: Acta biomaterialia [Acta Biomater] 2023 Oct 15; Vol. 170, pp. 453-463. Date of Electronic Publication: 2023 Aug 29.

B-cell-specific checkpoint molecules that regulate anti-tumour immunity.

Autor: Bod L; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Kye YC; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Shi J; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; BeiGene, Beijing, China., Torlai Triglia E; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Schnell A; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Fessler J; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Division of Immunology and Pathophysiology, Medical University of Graz, Graz, Austria., Ostrowski SM; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA., Von-Franque MY; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA., Kuchroo JR; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA., Barilla RM; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Zaghouani S; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA., Christian E; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Delorey TM; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Mohib K; Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Xiao S; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA., Slingerland N; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Giuliano CJ; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ashenberg O; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Li Z; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Rothstein DM; Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Fisher DE; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA., Rozenblatt-Rosen O; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Howard Hughes Medical Institute, Department of Biology and Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Sharpe AH; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA., Quintana FJ; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Howard Hughes Medical Institute, Department of Biology and Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Apetoh L; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.; INSERM, Tours, France.; Faculté de Médecine, Université de Tours, Tours, France., Regev A; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA. aviv.regev.sc@gmail.com.; Howard Hughes Medical Institute, Department of Biology and Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. aviv.regev.sc@gmail.com.; Genentech, San Francisco, CA, USA. aviv.regev.sc@gmail.com., Kuchroo VK; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA. vkuchroo@rics.bwh.harvard.edu.; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA. vkuchroo@rics.bwh.harvard.edu.; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. vkuchroo@rics.bwh.harvard.edu.

Publikováno v: Nature [Nature] 2023 Jul; Vol. 619 (7969), pp. 348-356. Date of Electronic Publication: 2023 Jun 21.

Topical corticosteroids for noninvasive treatment of pyogenic granulomas.

Autor: Moustafa D; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA., Neale H; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.; University of Massachusetts School of Medicine, Worcester, MA, USA., Ostrowski SM; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA., Gellis SE; Harvard Medical School, Boston, MA, USA.; Dermatology Program, Department of Immunology, Boston Children's Hospital, Boston, MA, USA., Hawryluk EB; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.; Dermatology Program, Department of Immunology, Boston Children's Hospital, Boston, MA, USA.

Publikováno v: Pediatric dermatology [Pediatr Dermatol] 2021 Nov; Vol. 38 Suppl 2, pp. 149-151. Date of Electronic Publication: 2021 Jul 16.

Biology of Melanoma.

Autor: Ostrowski SM; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Bartlett 6, 55 Fruit Street, Boston, MA 02114, USA., Fisher DE; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Bartlett 6, 55 Fruit Street, Boston, MA 02114, USA. Electronic address: dfisher3@partners.org.

Publikováno v: Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2021 Feb; Vol. 35 (1), pp. 29-56. Date of Electronic Publication: 2020 Oct 26.